169 related articles for article (PubMed ID: 19561530)
1. Efficacy of 5-ASA in the treatment of colonic diverticular disease.
Gatta L; Vakil N; Vaira D; Pilotto A; Curlo M; Comparato G; Leandro G; Ferro U; Lera M; Milletti S; Di Mario F
J Clin Gastroenterol; 2010 Feb; 44(2):113-9. PubMed ID: 19561530
[TBL] [Abstract][Full Text] [Related]
2. Mesalamine (5-ASA) for the prevention of recurrent diverticulitis.
Carter F; Alsayb M; Marshall JK; Yuan Y
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009839. PubMed ID: 28973845
[TBL] [Abstract][Full Text] [Related]
3. Mesalazine for People with Diverticular Disease: A Systematic Review of Randomized Controlled Trials.
Iannone A; Ruospo M; Wong G; Barone M; Principi M; Di Leo A; Strippoli GFM
Can J Gastroenterol Hepatol; 2018; 2018():5437135. PubMed ID: 30320044
[TBL] [Abstract][Full Text] [Related]
4. Effect of mesalazine on recurrence of diverticulitis in patients with symptomatic uncomplicated diverticular disease: a meta-analysis with trial sequential analysis of randomized controlled trials.
Khan RMA; Ali B; Hajibandeh S; Hajibandeh S
Colorectal Dis; 2018 Jun; 20(6):469-478. PubMed ID: 29520987
[TBL] [Abstract][Full Text] [Related]
5. Use of mesalazine in diverticular disease.
Di Mario F; Comparato G; Fanigliulo L; Aragona G; Cavallaro LG; Cavestro GM; Franzé A
J Clin Gastroenterol; 2006 Aug; 40 Suppl 3():S155-9. PubMed ID: 16885700
[TBL] [Abstract][Full Text] [Related]
6. Long-term treatment with mesalazine in patients with symptomatic uncomplicated diverticular disease.
Gatta L; Di Mario F; Curlo M; Vaira D; Pilotto A; Lucarini P; Lera M; Enkleda K; Franzé A; Scarpignato C
Intern Emerg Med; 2012 Apr; 7(2):133-7. PubMed ID: 21279478
[TBL] [Abstract][Full Text] [Related]
7. Review article: the pathophysiology and medical management of diverticulosis and diverticular disease of the colon.
Tursi A; Papa A; Danese S
Aliment Pharmacol Ther; 2015 Sep; 42(6):664-84. PubMed ID: 26202723
[TBL] [Abstract][Full Text] [Related]
8. Mesalazine to treat symptomatic uncomplicated diverticular disease and to prevent acute diverticulitis occurrence. A systematic review with meta-analysis of randomized, placebo-controlled trials.
Picchio M; Elisei W; Tursi A
J Gastrointestin Liver Dis; 2018 Sep; 27(3):291-297. PubMed ID: 30240473
[TBL] [Abstract][Full Text] [Related]
9. Is mesalazine treatment effective in the prevention of diverticulitis? A review.
Stefanelli G; Viscido A; Valvano M; Vernia F; Frieri G; Ashktorab H; Latella G
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8164-8176. PubMed ID: 32767345
[TBL] [Abstract][Full Text] [Related]
10. Aminosalicylates.
Gross V
Dig Dis; 2012; 30(1):92-9. PubMed ID: 22572694
[TBL] [Abstract][Full Text] [Related]
11. The metabolism of mesalamine and its possible use in colonic diverticulitis as an anti-inflammatory agent.
Cohen HD; Das KM
J Clin Gastroenterol; 2006 Aug; 40 Suppl 3():S150-4. PubMed ID: 16885699
[TBL] [Abstract][Full Text] [Related]
12. Mesalazine for the Treatment of Symptomatic Uncomplicated Diverticular Disease of the Colon and for Primary Prevention of Diverticulitis: A Systematic Review of Randomized Clinical Trials.
Picchio M; Elisei W; Brandimarte G; Di Mario F; Malfertheiner P; Scarpignato C; Tursi A
J Clin Gastroenterol; 2016 Oct; 50 Suppl 1():S64-9. PubMed ID: 27622370
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Diverticular Disease With Aminosalicylates: The Evidence.
Barbara G; Cremon C; Barbaro MR; Bellacosa L; Stanghellini V
J Clin Gastroenterol; 2016 Oct; 50 Suppl 1():S60-3. PubMed ID: 27622369
[TBL] [Abstract][Full Text] [Related]
14. Prevention of complications and symptomatic recurrences in diverticular disease with mesalazine: a 12-month follow-up.
Comparato G; Fanigliulo L; Cavallaro LG; Aragona G; Cavestro GM; Iori V; Maino M; Mazzocchi G; Muzzetto P; Colla G; Sianesi M; Franzé A; Mario FD
Dig Dis Sci; 2007 Nov; 52(11):2934-41. PubMed ID: 17410435
[TBL] [Abstract][Full Text] [Related]
15. Mesalazine for diverticular disease of the colon--a new role for an old drug.
Tursi A
Expert Opin Pharmacother; 2005 Jan; 6(1):69-74. PubMed ID: 15709884
[TBL] [Abstract][Full Text] [Related]
16. Review article: the current and evolving treatment of colonic diverticular disease.
Tursi A; Papagrigoriadis S
Aliment Pharmacol Ther; 2009 Sep; 30(6):532-46. PubMed ID: 19549266
[TBL] [Abstract][Full Text] [Related]
17. Emerging therapies for diverticular disease of the colon.
Trivedi CD; Das KM;
J Clin Gastroenterol; 2008; 42(10):1145-51. PubMed ID: 18936655
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology and Therapeutic Strategies for Symptomatic Uncomplicated Diverticular Disease of the Colon.
Scaioli E; Colecchia A; Marasco G; Schiumerini R; Festi D
Dig Dis Sci; 2016 Mar; 61(3):673-83. PubMed ID: 26458921
[TBL] [Abstract][Full Text] [Related]
19. Treatment of diverticular disease of the colon and prevention of acute diverticulitis: a systematic review.
Maconi G; Barbara G; Bosetti C; Cuomo R; Annibale B
Dis Colon Rectum; 2011 Oct; 54(10):1326-38. PubMed ID: 21904150
[TBL] [Abstract][Full Text] [Related]
20. [Modern indications on the medical treatment of symptomatic diverticular disease].
Ierfone N; Di Fulvio A; Pontone S; Terzakis P; Martino G; Pontone P
G Chir; 2006 Mar; 27(3):93-6. PubMed ID: 16681868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
